Discover Our New CTMS
Monday, May 14, 2012 | 4:51 PM
Will Use Trial Interactive eTMF Platform to Optimize Global Document Management and Increase Efficiencies in Study Delivery
NEW YORK, May 14, 2012 – TransPerfect, a leading provider of eClinical technologies to the life sciences industry, today announced that INC Research, a therapeutically focused clinical research organization (CRO), has selected Trial Interactive as its global electronic Trial Master File (eTMF) solution. Trial Interactive is a secure, web-based platform that reduces the redundancies inherent in paper-based TMF management.
“We chose Trial Interactive as our eTMF solution because it offers the greatest compatibility with current and potential customers,” said Todd Esporas, Executive Director of Clinical Development Services at INC Research. “The system creates efficiencies across our organization and further demonstrates our position as a leading partner to the biopharmaceutical industry. By embracing the latest, most sophisticated technology to accelerate drug development, we are able to deliver clinical trials on behalf of our customers more efficiently.”
As a top global CRO, optimizing the collection and management of TMFs worldwide is a critical task for INC Research. Trial Interactive enables INC Research to deliver trials more efficiently by allowing real-time access to global project documentation, eliminating much of the travel and shipping associated with TMF reviews and reconciliation, and providing a real-time metrics dashboard to enhance communications with customers and stakeholders. Trial Interactive’s interface is available in more than 20 languages, which will enable INC Research to deploy the solution in the local language of the end user, making it ideal for global study teams, sponsors, and investigative site personnel involved in the conduct of multinational clinical trials.
Michael Smyth, General Manager of TransPerfect’s Life Science Solutions division, stated, “We’re very proud that INC Research has chosen Trial Interactive as its eTMF solution. INC’s global reach and commitment to utilizing technology should only serve to benefit their study sponsors as they seek to become more efficient in conducting global clinical trials.”
About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The Company's Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.
About Trial Interactive
TransPerfect’s Trial Interactive solution provides a collaborative, web-based platform for clinical development that enables sponsors, CROs, IRBs, and other vendors to maintain and update clinical trial documentation in a secure online environment, adhering to global regulatory requirements. With fully searchable solutions including investigator portals, Trial Interactive streamlines study timelines and reduces the administrative burdens of global clinical trials. As part of TransPerfect’s Life Sciences division, Trial Interactive is dedicated to working with clients on a global, collaborative level, supporting a wide range of requirements including e-feasibility, study start-up, eTMF review/reconciliation, mobile applications, learning management and document management systems, investigator portals, pharmacovigilance and safety management, and endpoint adjudication. For more information on Trial Interactive, please contact firstname.lastname@example.org or +1 212.400.8848, or visit www.trialinteractive.com.
TransPerfect is the world’s largest provider of language services and technology solutions for global business. From offices in over 90 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. More than 4,000 global organizations employ TransPerfect’s GlobalLink® Product Suite to simplify management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.